HuGE Literature Finder
Records
1
-
5
MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis. Mutagenesis 2017 Oct 32 (5): 533-542. Schneiderova Michaela, Naccarati Alessio, Pardini Barbara, Rosa Fabio, Gaetano Cornelia Di, Jiraskova Katerina, Opattova Alena, Levy Miroslav, Veskrna Karel, Veskrnova Veronika, Buchler Tomas, Landi Stefano, Vodicka Pavel, Vymetalkova Veroni |
Genome-wide network-based pathway analysis of CSF t-tau/Aß1-42 ratio in the ADNI cohort. BMC genomics 2017 May 18 (1): 421. Cong Wang, Meng Xianglian, Li Jin, Zhang Qiushi, Chen Feng, Liu Wenjie, Wang Ying, Cheng Sipu, Yao Xiaohui, Yan Jingwen, Kim Sungeun, Saykin Andrew J, Liang Hong, Shen Li, |
Effect of APE1 T2197G (Asp148Glu) polymorphism on APE1, XRCC1, PARP1 and OGG1 expression in patients with colorectal cancer. International journal of molecular sciences 2014 15 (10): 17333-43. Santos Juliana C, Funck Alexandre, Silva-Fernandes Isabelle J L, Rabenhorst Silvia H B, Martinez Carlos A R, Ribeiro Marcelo |
Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a northeast Chinese population. Medical oncology (Northwood, London, England) 2013 Jun 30 (2): 505. Li Ye, Li Shuying, Wu Zhiwei, Hu Fulan, Zhu Lin, Zhao Xiaojuan, Cui Binbin, Dong Xinshu, Tian Suli, Wang Fan, Zhao Yashua |
Irinotecan pharmacogenetics: influence of pharmacodynamic genes. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Mar 14 (6): 1788-96. Hoskins Janelle M, Marcuello Eugenio, Altes Albert, Marsh Sharon, Maxwell Taylor, Van Booven Derek J, Paré Laia, Culverhouse Robert, McLeod Howard L, Baiget Montserr |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: